The course will be delivered in two parts; the first section will focus on the theoretical aspects of each biophysical method in a seminar format and in the following section their practical applications will be brought to light in an open and active discussion format. For the first section, you will receive a series of brief high-level presentations concerning the biophysical theory behind each technology and their application in lead finding, hit validation as well as more in depth mechanistic studies. This will enable you to gain a rapid overview of the most relevant biophysics/ label-free technologies for screening and lead finding/characterization. In the second section you will be presented with some challenges on how to effectively apply those technologies by looking at a range of common scenarios from different phases of lead discovery. This will include fragment-based drug discovery, hit validation and confirmation, in-depth hit characterization and support of HTS assay development. Making use of an active and open discussion forum, you, as a part of a team, will thereby gain further insight about the usage, impact, and limitations of each biophysical technology.
Who Should Attend? • People interested in getting an overview about the current toolbox of affinity-based, biophysical methods currently applied in drug discovery. • Experts in one of the fields (biophysical technologies) that want to learn more about other orthogonal approaches. • Project leaders that want to understand what technologies suit their needs and how to place them correctly in finding and characterizing chemical leads. • Medicinal chemists that want to learn more about the generation of biophysical data used in drug design. • Technology providers that want to gain more insight into the needs of typical users and the limitations they experience.
How You Will Benefit From This Course? • Get a broad overview about what is available and state of the art in the field. • Comprehend which technology best fits to individual project needs and scientific questions. • Learn about typical applications and "best practice" as well as limitations and practical considerations. • Understand how the biophysics technologies relate to each other and how they augment and synergize with data from other approaches. • Be able to predict for a project which technology (or combinations thereof) serves best in a typical drug discovery flowchart along with its placement.
Course Topics: • Overview of the most relevant biochemical biophysics/ label-free technologies for screening and lead finding. • Main technologies discussed in more detail: Mass Spectrometry; NMR; Calorimetry (DSC, ITC); SPR; Interferometry; Resonance Waveguide Grating (aka Corning Epic); thermal protein denaturation and aggregation assays (DSF aka Thermofluor, DSLS aka Stargazer, CETSA; nanoDSF); Dynamic Light Scattering; Microscale Thermophoresis (NanoTemper). • Understand which technology and combinations thereof fits best to answer specific questions throughout the entire drug discovery process. • Grasp how biophysics can support assay development for screening and how biophysical data can be used to fuel medicinal chemistry design.
Course Pre-Reading Requirements: General introduction into affinity-based methods and their application in Drug Discovery: (articles which describe how the approaches work, caveats, and a summary of their impact) 1. Integrating biophysics with HTS-driven drug discovery projects Folmer, Rutger H.A. Drug Discovery Today, March 2016, Vol.21(3), pp.491-498 Identifier: ISSN: 1359-6446 ; DOI: 10.1016/j.drudis.2016.01.011 2. Applications of Biophysics in High-Throughput Screening Hit Validation Genick, Christine Clougherty ; Barlier, Danielle ; Monna, Dominique ; Brunner, Reto ; Bé, Céline ; Scheufler, Clemens ; Ottl, Johannes Journal of biomolecular screening, June 2014, Vol.19(5), pp.707-14 Identifier: E-ISSN: 1552-454X ; PMID: 24695619 Version:1 ; DOI: 10.1177/1087057114529462 3. Biophysics in Drug Discovery: impact, challenges, and opportunities, Jean-Paul Renaud, Chun wa Chung, U. Helena Danielson, Ursula Egner, Michael Hennig, Roderick E. Hubbard, and Herbert Nar Nature Reviews, August 2016, Vol.15(10), pp. 679-98 DOI: 10.1038/nrd.2016.123 Background Information on each technology/approach: • DLS: Making sense of Brownian motion: colloid characterization by dynamic light scattering Hassan, Puthusserickal A ; Rana, Suman ; Verma, Gunjan Langmuir: the ACS journal of surfaces and colloids, 13 January 2015, Vol.31(1), pp.3-12 Identifier: E-ISSN: 1520-5827 ; PMID: 25050712 Version:1 DOI: 10.1021/la501789z • TSA: Thermal denaturation assays in chemical biology Senisterra, Guillermo ; Chau, Irene ; Vedadi, Masoud Assay and drug development technologies, April 2012, Vol.10(2), pp.128-36 Identifier: E-ISSN: 1557-8127 ; PMID: 22066913 Version:1 DOI: 10.1089/adt.2011.0390 • CETSA: The cellular thermal shift assay for evaluating drug target interactions in cells Jafari, Rozbeh ; Almqvist, Helena ; Axelsson, Hanna ; Ignatushchenko, Marina ; Lundbäck, Thomas ; Nordlund, Pär ; Martinez Molina, Daniel Nature protocols, September 2014, Vol.9(9), pp.2100-22 Identifier: E-ISSN: 1750-2799 ; PMID: 25101824 Version:1 DOI: 10.1038/nprot.2014.138 • MST: Microscale Thermophoresis: Interaction analysis and beyond Jerabek-Willemsen, Moran ; André, Timon ; Wanner, Randy ; Roth, Heide Marie ; Duhr, Stefan ; Baaske, Philipp ; Breitsprecher, Dennis Journal of Molecular Structure, 5 December 2014, Vol.1077, pp.101-113 Identifier: ISSN: 0022-2860 ; DOI: 10.1016/j.molstruc.2014.03.009 • MS: Affinity selection-mass spectrometry screening techniques for small molecule drug discovery Annis, D. Allen ; Nickbarg, Elliot ; Yang, Xianshu ; Ziebell, Michael R. ; Whitehurst, Charles E. Current Opinion in Chemical Biology, 2007, Vol.11(5), pp.518-526 • NMR: Parallel screening of low molecular weight fragment libraries: do differences in methodology affect hit identification? Wielens, Jerome ; Headey, Stephen J ; Rhodes, David I ; Mulder, Roger J ; Dolezal, Olan ; Deadman, John J ; Newman, Janet ; Chalmers, David K ; Parker, Michael W ; Peat, Thomas S ; Scanlon, Martin J Journal of biomolecular screening, February 2013, Vol.18(2), pp.147-59 Identifier: E-ISSN: 1552-454X ; PMID: 23139382 Version:1 DOI: 10.1177/1087057112465979 • SPR: Biomolecular interaction analysis in drug discovery using surface plasmon resonance technology Huber, W ; Mueller, F Current Pharmaceutical Design, 2006, Vol.12(31), pp.3999-4021 Identifier: ISSN: 1381-6128 • RWG: Resonant waveguide grating for monitoring biomolecular interactions Wu, Meng ; Li, Min Methods in molecular biology (Clifton, N.J.), 2015, Vol.1278, pp.139-52 Identifier: E-ISSN: 1940-6029 ; PMID: 25859947 Version:1 ; DOI: 10.1007/978-1-4939-2425-7_8 • ITC: Direct measurement of protein binding energetics by isothermal titration calorimetry Leavitt, Stephanie ; Freire, Ernesto Current Opinion in Structural Biology, 2001, Vol.11(5), pp.560-566 Identifier: ISSN: 0959-440X ; DOI: 10.1016/S0959-440X(00)00248-7 • Xray: Effective and Emerging Strategies for utilizing Structure in Drug Discovery Brown, Ka ; Davenport, R ; Ward, Se Drugs Of The Future, 2015 Apr, Vol.40(4), pp.251-256 [Peer Reviewed Journal] Identifier: ISSN: 0377-8282 ; DOI: 10.1358/dof.2015.040.04.2314768